首页 | 本学科首页   官方微博 | 高级检索  
     


Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study
Authors:Mehmet Ak  Suheyla Dogan Bulut  Ali Bozkurt  Aytekin Ozsahin
Affiliation:Gulhane School of Medicine, Etlik-Ankara, Turkey. drmehmetak@gmail.com
Abstract:

Introduction  

Studies investigating the aripiprazole augmentation treatment of serotonin reuptake inhibitor (SRI)-resistant obsessive-compulsive disorder (OCD) are insufficient. The aim of the present pilot study was to investigate the efficacy and tolerability of flexible doses of aripiprazole as an augmenting agent in SRI-resistant OCD patients.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号